Metcela

Kawasaki, Japan

Metcela is a clinical-stage biotech startup providing patients with an alternative treatment option for heart disease.

$13.7M raised

Jun 2022

Series C

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Metcela raised?

Metcela has raised $13.7M in total funding. The most recent round was Series C. The last funding was announced in June 2022.

Who are Metcela's investors?

Metcela's investors include UTEC - The University of Tokyo Edge Capital Partners, Beyond Next Ventures, Sony, Sony Innovation Fund, KSP.

Where is Metcela headquartered?

Metcela is headquartered in Kawasaki, Japan.

What does Metcela do?

Metcela is a clinical-stage biotech startup providing patients with an alternative treatment option for heart disease.

What stage is Metcela at?

Metcela is at the Series C stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 28, 2022.

MLA

"Metcela — Funding & Investors." VCBacked, June 28, 2022, https://www.vcbacked.co/company/metcela. Accessed July 2, 2026.

APA

VCBacked. (2022). Metcela — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/metcela

Wikipedia (cite web)

{{cite web |title=Metcela — Funding & Investors |url=https://www.vcbacked.co/company/metcela |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 28, 2022.